Translation. Region: Russian Federal
Source: Novosibirsk State University –
An important disclaimer is at the bottom of this article.
Novosibirsk State University and Binnopharm Group, one of the largest pharmaceutical manufacturers in Russia, have agreed to cooperate in the educational and research fields. The corresponding agreement was signed today at the international forum for technological development Technoprom-2025. The university will train specialists for the company within the framework of the new master's program Industrial Pharmacy, which opened this year at the Institute of Medicine and Medical Technologies (IMMT) of NSU.
— Biotechnology and medical research are one of the priority areas that will be developed on the basis of the infrastructure of the new educational and scientific center of the NSU IMMT and the NSU research center, which are objects of the NSU campus under construction. Also this year we launched new educational programs, including the specialty "Medical Cybernetics". Partnership with one of the market leaders will allow us to adapt our educational programs to the current requirements of pharmaceutical manufacturers and train specialists who will be in demand in the labor market. And also to work at the forefront of science in the field of medical biotechnology and the development of new drugs, — commented the rector of NSU, academician of the Russian Academy of Sciences Mikhail Fedoruk.
The infrastructure of the new NSU campus, which is one of the priority projects for the development of the Novosibirsk Region and is being implemented within the framework of the federal project “Creation of a network of modern campuses” of the national project “Youth and Children”, allows working with a wide range of technological platforms – from gene therapy to cellular technologies, which is intended to make a significant contribution to achieving the goal of ensuring technological leadership of the country.
The future campus space will meet modern requirements and demands of the student community. Design solutions will allow creating unique scientific and educational centers, as well as additional coworking areas. The campus will serve as the foundation for a modern comfortable environment for students and teachers.
— Pharmaceuticals is one of the most dynamic and knowledge-intensive industries. Success here is determined not only by fundamental knowledge, but also by the ability to innovate, so for us, the partnership with NSU is a strategic investment in the future of the industry, — noted Tatyana Fedchenko, Director of HR and Organizational Development at Binnopharm Group. — Binnopharm Group systematically builds work with the country's leading universities. We organize internships, practical training and excursions so that students can get acquainted with modern production during their studies. This year alone, more than 200 students have completed such programs. This allows us not only to fill vacancies, but to attract motivated and promising specialists to the company who are already familiar with our standards.
In addition to cooperation in implementing the master's program, NSU plans to launch educational courses for additional professional education in order to train specialists with unique competencies required for the enterprises of Binnopharm Group. This concerns postgraduate training in the field of pharmacy.
In the future, it is planned to expand the scope of cooperation and conduct joint research projects in the field of biomedical developments that are relevant to the modern scientific agenda.
— The cooperation between NSU and the Binnopharm Group company will allow us to more effectively build the entire chain of product creation: starting with joint development based on our laboratories, the release of pilot industrial batches and ending with further scaling at the company's production sites, — said Yulia Samoilova, Director of the NSU Institute of Medical Technologies.
In order to implement the full cycle of development of innovative medical products and drugs, as well as bring them to the stage of production of pilot industrial series under GMP (Good Manufacturing Practice) conditions, a complex of high-tech clean rooms and laboratories that meet the most stringent international standards will be created at the university on the basis of the new campus.
Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.
.